The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA UPDATED PEPTIDES APRIL 15, 2026 Most people are already getting this wrong. Today, the FDA updated its 503A compounding categories and removed several peptides from the high risk (Category 2) Are Peptides coming off of the FDA Category 2 list? A legal breakdown. FDA Peptide Reclassification 2026: What It Means for Providers You may have heard buzz about 14 peptides potentially returning to legal compounding. Here's what we know: HHS Secretary RFK Jr. stated his intention to move these peptides from FDA Category 2